Posted inClinical Trials, Rare/Orphan Diseases Wynayre/Wynfidra: New Drug for COPD Maintenance Therapy August 9, 2022September 8, 2022 Ensifentrine, an inhaled PDE3/PDE4 inhibitor, in the treatment of chronic obstructive pulmonary disease.